296 related articles for article (PubMed ID: 21170492)
1. [Effects of amyloid β-protein on hippocampal long-term potentiation].
Zhang JF; Yang D; Qi JS
Sheng Li Xue Bao; 2010 Dec; 62(6):479-88. PubMed ID: 21170492
[TBL] [Abstract][Full Text] [Related]
2. [Chronic effects of oligomeric Aβ(1-42) on hippocampal synaptic plasticity in vivo].
Tan T; Zhang BL; Tian X
Sheng Li Xue Bao; 2011 Jun; 63(3):225-32. PubMed ID: 21681340
[TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
4. Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
[TBL] [Abstract][Full Text] [Related]
5. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
6. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
Bisel BE; Henkins KM; Parfitt KD
Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
Zhang JF; Qi JS; Qiao JT
Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
[TBL] [Abstract][Full Text] [Related]
9. Requirement of α7 nicotinic acetylcholine receptors for amyloid β protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo.
Li SF; Wu MN; Wang XH; Yuan L; Yang D; Qi JS
Synapse; 2011 Nov; 65(11):1136-43. PubMed ID: 21584864
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
Nomura I; Kato N; Kita T; Takechi H
Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
[TBL] [Abstract][Full Text] [Related]
11. Intraneuronally injected amyloid β inhibits long-term potentiation in rat hippocampal slices.
Nomura I; Takechi H; Kato N
J Neurophysiol; 2012 May; 107(9):2526-31. PubMed ID: 22338026
[TBL] [Abstract][Full Text] [Related]
12. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
Wu MN; He YX; Guo F; Qi JS
Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
[TBL] [Abstract][Full Text] [Related]
13. The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat.
Shahidi S; Asl SS; Komaki A; Hashemi-Firouzi N
Psychopharmacology (Berl); 2018 May; 235(5):1513-1525. PubMed ID: 29637287
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
[TBL] [Abstract][Full Text] [Related]
15. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol, synaptic function and Alzheimer's disease.
Koudinov AR; Koudinova NV
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S107-12. PubMed ID: 14574623
[TBL] [Abstract][Full Text] [Related]
17. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
18. Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.
Lee CC; Kuo YM; Huang CC; Hsu KS
Neurobiol Aging; 2009 Mar; 30(3):377-87. PubMed ID: 17692997
[TBL] [Abstract][Full Text] [Related]
19. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
Rowan MJ; Klyubin I; Wang Q; Hu NW; Anwyl R
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1219-23. PubMed ID: 17956317
[TBL] [Abstract][Full Text] [Related]
20. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]